Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anaplastic large-cell lymphoma, T-/null-cell type.

Eric Jacobsen1

  • 1Harvard Medical School, Dana-Farber Cancer Institute, Dana 1B30, 44 Binney Street, Boston, Massachusetts 02115, USA. Eric_Jacobsen@dfci.harvard.edu

The Oncologist
|August 2, 2006
PubMed
Summary

Anaplastic large-cell lymphoma (ALCL) is a rare lymphoma. This review details ALCL pathophysiology, clinical presentation, and therapies, highlighting how new insights impact treatment and drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns.

Haematologica·2026
Same author

Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective study.

Leukemia & lymphoma·2026
Same author

Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.

Leukemia & lymphoma·2026
Same author

Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin Lymphoma.

Clinical and translational science·2025
Same author

Influence of Rolfing Structural Integration on Lower Limb Mobility, Respiratory Thorax Mobility, and Trunk Symmetry: A Retrospective Cohort Study.

Journal of clinical medicine·2025

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Anaplastic large-cell lymphoma (ALCL), T-/null-cell type, is a distinct lymphoma subtype.
  • While rare, ALCL's biology is relatively well-understood compared to other lymphomas.
  • Characterization of ALCL has advanced significantly over the past two decades.

Purpose of the Study:

  • To review the pathophysiology, clinical presentation, and therapeutic strategies for ALCL.
  • To highlight the impact of emerging prognostic factors and biological insights on ALCL management.
  • To discuss the implications for future drug development in ALCL.

Main Methods:

  • Literature review focusing on ALCL pathophysiology, clinical features, and treatment modalities.
  • Analysis of current therapeutic approaches, including stem cell transplantation.
  • Synthesis of recent findings on prognostic markers and disease biology.

Main Results:

  • ALCL exhibits unique pathobiological features influencing its clinical course.
  • Current therapies for ALCL are evolving based on a deeper understanding of the disease.
  • Novel prognostic markers are emerging, aiding in risk stratification and treatment selection.

Conclusions:

  • An evolving understanding of ALCL biology is crucial for optimizing patient outcomes.
  • Personalized treatment strategies and targeted drug development are key for advancing ALCL therapy.
  • Continued research into ALCL pathophysiology and prognostication will refine clinical management.

Related Experiment Videos